BioCentury | Jul 15, 2013
Emerging Company Profile

Oxford Cancer: Functional silence is golden

...associated with a higher rate of disease stabilization. In January 2012, the university spun out Oxford Cancer Biomarkers...
..."We are getting to the stage where Quintiles will take our biomarkers into clinical development." Oxford Cancer Biomarkers...
...biomarkers generated through CancerNav. Oxford Cancer Biomarkers would then be eligible to receive development and sales milestones. Oxford Cancer Biomarkers...
BioCentury | Jan 23, 2012
Company News

University of Oxford cancer, pharmacogenetics news

...The University of Oxford spun out Oxford Cancer Biomarkers Ltd. (Oxford, U.K.) to discover cancer biomarkers and provide cancer...
...made a £3 million ($4.6 million) investment in the newco, which represents a 27.5% stake. Oxford Cancer Biomarkers...
BioCentury | Jan 23, 2012
Financial News

Oxford Cancer Biomarkers completes venture financing

Oxford Cancer Biomarkers Ltd. , Oxford, U.K. Business: Cancer Date completed: 1/18/12 Type: Venture financing Raised: £3 million ($4.6 million) Investor: Quintiles Transnational WIR Staff...
BioCentury | Jan 19, 2012
Financial News

Oxford spins out biomarker company

...The University of Oxford spun out Oxford Cancer Biomarkers Ltd. (Oxford, U.K.) to discover cancer biomarkers and provide cancer...
...made a L3 million ($4.6 million) investment in the newco, which represents a 27.5% stake. Oxford Cancer Biomarkers...
Items per page:
1 - 4 of 4
BioCentury | Jul 15, 2013
Emerging Company Profile

Oxford Cancer: Functional silence is golden

...associated with a higher rate of disease stabilization. In January 2012, the university spun out Oxford Cancer Biomarkers...
..."We are getting to the stage where Quintiles will take our biomarkers into clinical development." Oxford Cancer Biomarkers...
...biomarkers generated through CancerNav. Oxford Cancer Biomarkers would then be eligible to receive development and sales milestones. Oxford Cancer Biomarkers...
BioCentury | Jan 23, 2012
Company News

University of Oxford cancer, pharmacogenetics news

...The University of Oxford spun out Oxford Cancer Biomarkers Ltd. (Oxford, U.K.) to discover cancer biomarkers and provide cancer...
...made a £3 million ($4.6 million) investment in the newco, which represents a 27.5% stake. Oxford Cancer Biomarkers...
BioCentury | Jan 23, 2012
Financial News

Oxford Cancer Biomarkers completes venture financing

Oxford Cancer Biomarkers Ltd. , Oxford, U.K. Business: Cancer Date completed: 1/18/12 Type: Venture financing Raised: £3 million ($4.6 million) Investor: Quintiles Transnational WIR Staff...
BioCentury | Jan 19, 2012
Financial News

Oxford spins out biomarker company

...The University of Oxford spun out Oxford Cancer Biomarkers Ltd. (Oxford, U.K.) to discover cancer biomarkers and provide cancer...
...made a L3 million ($4.6 million) investment in the newco, which represents a 27.5% stake. Oxford Cancer Biomarkers...
Items per page:
1 - 4 of 4